The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Open accessAbstract
Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles in brains of individuals with Alzheimer's disease (AD) and other tauopathies. Tau pathology is critical to pathogenesis and correlates to the severity of dementia. However, the mechanisms leading to abnormal hyperphosphorylation are unknown. Here, we demonstrate that human brain tau was modified by O-GlcNAcylation, a type of protein O-glycosylation by which the monosaccharide β- N -acetylglucosamine (GlcNAc) attaches to serine/threonine residues via an O-linked glycosidic bond. O-GlcNAcylation regulated phosphorylation of tau in a site-specific manner both in vitro and in vivo . At most of the phosphorylation sites, O-GlcNAcylation negatively regulated tau phosphorylation. In an animal model of starved mice, low glucose uptake/metabolism that mimicked those observed in AD brain produced a decrease in O-GlcNAcylation and consequent hyperphosphorylation of tau at the majority of the phosphorylation sites. The O-GlcNAcylation level in AD brain extracts was decreased as compared to that in controls. These results reveal a mechanism of regulation of tau phosphorylation and suggest that abnormal hyperphosphorylation of tau could result from decreased tau O-GlcNAcylation, which probably is induced by deficient brain glucose uptake/metabolism in AD and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a reduction of glucose consumption induces an increase in phospho-Tau and A β accumulation (Fu et al., 2015; Liu et al., 2004).”
From Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease (2024) · cites this paper as Liu et al., 2004
Experimental — accuracy not yet measuredIn the citing paper
“For example, reduced tau O-glycosylation could lead to increased phosphorylation, while the enhancement of O-glycosylation reduces the extent of tau phosphorylation [43–45].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [43]
In the citing paper
“As discussed above, a reciprocal relationship has been found between O-GlcNAcylation and phosphorylation on tau [43].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Self-citationA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Köpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Self-citation
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Roos, M. D., Xie, W., Su, K., Clark, J. A., Yang, X., Chin, E., Paterson, A. J. & Kudlow, J. E. (1998) Proc. Assoc. Am. Physicians 110, 422-432.9756093
- Iqbal, K. & Grundke-Iqbal, I. (2000) Neurosci. News 3, 14-20.
- Xavier-Blaizot, A., Meguro, K., Millien, I., Baron, J.-C. & Chavoix, C. (2002) J. Neurosci. 21, 9166-9170.
Cited by
Sorted by citations
Items 301–400 of 781
Peng, D., Pan, X., Cui, J., Ren, Y., & Zhang, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356579 · Cited by 45
Recent developments with tau-based drug discovery
Iqbal, K., Liu, F., & Gong, C. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1445084 · Cited by 46
Self-citationTramutola, A., Sharma, N. K., Barone, E., Lanzillotta, C., Castellani, A., Iavarone, F., Vincenzoni, F., Castagnola, M., Butterfield, D. A., Gaetani, S., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.017 · Cited by 44
Sugar Chains of Cerebrospinal Fluid Transferrin as a New Biological Marker of Alzheimer’s Disease
Taniguchi, M., Okayama, Y., Hashimoto, Y., 北浦美貴, Jimbo, D., Wakutani, Y., Wada‐Isoe, K., Nakashima, K., Akatsu, H., Furukawa, K., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000147479 · Cited by 45
Fehsel, K., & Christl, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101592 · Cited by 42
Emerging roles of O-glycosylation in regulating protein aggregation, phase separation, and functions
Li, X., Lv, P., Du, Y., Chen, X., & Liu, C. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102314 · Cited by 43
Beta-Amyloid Impairs Reelin Signaling
Cuchillo‐Ibáñez, I., Balmaceda, V., Botella-López, A., Rábano, A., Ávila, J., & Sáez‐Valero, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072297 · Cited by 42
Gu, Y., Gao, J.-G., Han, C., Zhang, X., Liu, H., Ma, L., SUN, X., & Yu, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2269 · Cited by 43
Cekic, N., Heinonen, J. E., Stubbs, K. A., Roth, C., He, Y., Bennet, A. J., McEachern, E. J., Davies, G. J., & Vocadlo, D. J. (2016) · Chemical Science · doi:10.1039/c6sc00370b · Cited by 43
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 43
Novel therapeutics for Alzheimer's disease: an update.
Bonda, D., Lee, H. P., Lee, H., Friedlich, A. L., Perry, G. L., Zhu, X., & Smith, M. A. (2010) · PubMed · Cited by 41
Yoon, S., Park, J.-S., Choi, J., Choi, J.-M., Lee, W.-J., Kim, S.-W., & Kim, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.005 · Cited by 43
Glawar, A. F. G., Best, D., Ayers, B. J., Miyauchi, S., Nakagawa, S., Aguilar‐Moncayo, M., Fernández, J. M. G., Mellet, C. O., Crabtree, E. V., Butters, T. D., et al. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200110 · Cited by 42
Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice
Khoury, N. B. E., Gratuze, M., Petry, F. R., Papon, M.-A., Julien, C., Marcouiller, F., Morin, F., Nicholls, S. B., Calon, F., Hébert, S. S., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.005 · Cited by 42
Yan, S. Z., Luo, B., He, J. W., Lan, F., & Wu, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02517h · Cited by 42
To target Tau pathologies, we must embrace and reconstruct their complexities
Limorenko, G., & Lashuel, H. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105536 · Cited by 41
Developing pharmacological therapies for Alzheimer disease
Iqbal, K., & Grundke, I. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7221-9 · Cited by 42
Self-citationLemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 45
Semi‐synthesis of a tag‐free O‐GlcNAcylated tau protein by sequential chemoselective ligation
Schwagerus, S., Reimann, O., Despres, C., Smet‐Nocca, C., & Hackenberger, C. P. R. (2016) · Journal of Peptide Science · doi:10.1002/psc.2870 · Cited by 41
Luo, B., Yan, S. Z., Zhang, Y., Zhou, J., Lan, F., & Wu, Y. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338761 · Cited by 41
Bai, Q., & Burton, E. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.004 · Cited by 42
Frank, L. A., Sutton‐McDowall, M. L., Brown, H. M., Russell, D. L., Gilchrist, R. B., & Thompson, J. G. (2014) · Human Reproduction · doi:10.1093/humrep/deu066 · Cited by 41
Diverse regulation of AKT and GSK‐3β by O‐GlcNAcylation in various types of cells
Shi, J., Wu, S., Dai, C., Li, Y., Grundke, I., Iqbal, K., Liu, F., & Gong, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.063 · Cited by 41
Self-citationInvited review: Drug development for tauopathies
Grüninger, F. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12192 · Cited by 40
He, Y., Zheng, Q., Huang, H., Ji, Y., & Lin, Z. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339552 · Cited by 40
OGT as potential novel target: Structure, function and inhibitors
Zhang, N., Jiang, H., Zhang, K., Zhu, J., Wang, Z., Long, Y., He, Y., Feng, F., Liu, W., Ye, F., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109886 · Cited by 45
Jeon, J. H., Suh, H. N., Kim, M., Ryu, J. M., & Han, H. J. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0583 · Cited by 40
The propagation mechanisms of extracellular tau in Alzheimer’s disease
Wei, Y., Liu, M., & Wang, D. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10573-y · Cited by 40
Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism
Zhao, Q., Zhou, S., Lou, W., Qian, H., & Xu, Z. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01473-z · Cited by 43
Domenico, F. D., Owen, J. B., Rukhsana Sultana, A., Robinson, R. A. S., Marzia Perluigi, A., Cini, C., Cai, J., Pierce, W. M. J., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22528 · Cited by 40
O-GlcNAcylation and neuronal energy status: Implications for Alzheimer’s disease
Pinho, T. S., Verde, D. V., Correia, S. C., Cardoso, S., & Moreira, P. I. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.003 · Cited by 41
Regulation of the Inositol 1,4,5-Trisphosphate Receptor Type I by O -GlcNAc Glycosylation
Rengifo, J., Gibson, C. J., Winkler, E., Collin, T., & Ehrlich, B. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2069-07.2007 · Cited by 38
Li, X., Han, J., Bujaranipalli, S., He, J., Kim, E. Y., Kim, H. Y., Im, J. H., & Cho, W. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114444 · Cited by 38
Herzfeld, T., Nolte, D., Grznarova, M., Hofmann, A., Schultze, J. L., & Müller, U. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds499 · Cited by 37
Wang, X., Smith, K. D. B., Pearson, M. S., Hughes, A. C., Cosden, M. L., Marcus, J., Hess, J. F., Savage, M. J., Rosahl, T. W., Smith, S. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195486 · Cited by 35
Frontrunner in Translation: Progressive Supranuclear Palsy
Shoeibi, A., Olfati, N., & Litvan, I. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01125 · Cited by 39
O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43’s mRNA splicing activity
Zhao, M., Xiao, Y., Wei, P. Y., Zhao, C. N., Cheng, M., Zhang, D., Xue, W., He, W.-T., Xue, W., Zuo, X., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051649 · Cited by 38
Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
Yin, X., Zhao, C., Qiu, Y., Zhou, Z., Bao, J., & Qian, W. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.671779 · Cited by 41
Butterfield, D. A., & Owen, J. B. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000070 · Cited by 38
Quail Sulf1 Function Requires Asparagine-linked Glycosylation
Ambasta, R. K., Ai, X., & Emerson, C. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706744200 · Cited by 37
Ahmad, W. (2018) · Experimental Brain Research · doi:10.1007/s00221-018-5341-0 · Cited by 36
Zhang, K., Hu, D., Deng, S., Han, M., Wang, X., Liu, H., Liu, Y., & Xie, M. (2019) · Microchimica Acta · doi:10.1007/s00604-018-3177-8 · Cited by 36
Early Stage Glycosylation Biomarkers in Alzheimer’s Disease
Regan, P., McClean, P. L., Smyth, T. J., & Doherty, M. (2019) · Medicines · doi:10.3390/medicines6030092 · Cited by 38
Zhang, W., Liu, X., Li, P., Zhang, W., Wang, H., & Tang, B. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04878 · Cited by 36
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 41
Self-citationHyperphosphorylation-induced self assembly of murine tau: a comparison with human tau
Chohan, M. O., Haque, N., Alonso, A., El-Akkad, E., Grundke, I., Grover, A., & Iqbal, K. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0241-9 · Cited by 36
Self-citationBroncel, M., Falenski, J. A., Wagner, S. C., Hackenberger, C. P. R., & Koksch, B. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902452 · Cited by 36
Characterization and identification of protein O-GlcNAcylation sites with substrate specificity
Wu, H.-Y., Lu, C.-T., Kao, H.-J., Chen, Y., Chen, Y., & Lee, T.-Y. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s16-s1 · Cited by 37
Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease
Lee, J. H., Oh, I., & Lim, H. K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.6.583 · Cited by 35
Pathological Alterations of Tau in Alzheimer’s Disease and 3xTg-AD Mouse Brains
Li, L., Jiang, Y., Hu, W. H., Tung, Y. C., Dai, C., Chu, D., Gong, C., Iqbal, K., & Liu, F. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1507-4 · Cited by 36
Self-citationGlycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease
Wang, W., Gopal, S., Pocock, R., & Xiao, Z. (2019) · Molecules · doi:10.3390/molecules24244604 · Cited by 36
Loss of O-GlcNAc transferase in neural stem cells impairs corticogenesis
Cheng, J., Wu, Y., Chen, L., Li, Y., Liu, F., Shao, J., Huang, M.-H., Fan, M., & Wu, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.084 · Cited by 35
Self-citationChemical Arsenal for the Study of O-GlcNAc
Kim, E. J. (2011) · Molecules · doi:10.3390/molecules16031987 · Cited by 35
O-GlcNAc cycling in the developing, adult and geriatric brain
Lagerlöf, O. (2018) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-018-9760-1 · Cited by 37
The Role of Insulin Resistance and Protein O-GlcNAcylation in Neurodegeneration
Ansari, S. A., & Emerald, B. S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00473 · Cited by 36
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Liu, J., Ting, J. P., Al-Azzam, S., Ding, Y., & Afshar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062805 · Cited by 37
Carroll, T., Guha, S. K., Nehrke, K. W., & Johnson, G. V. W. (2021) · Biology · doi:10.3390/biology10101047 · Cited by 39
Chen, L., Jiang, H., Licinio, J., & Wu, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02943-z · Cited by 33
Lu, S., Haskali, M. B., Ruley, K. M., Dreyfus, N., DuBois, S. L., Paul, S., Liow, J., Morse, C. L., Kowalski, A., Gladding, R. L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau2939 · Cited by 33
Altered glycosylation of acetylcholinesterase in Creutzfeldt–Jakob disease
Silveyra, M. X., Cuadrado‐Corrales, N., Marcos, A., Jiménez, M. S. B., Rábano, A., Calero, M., & Sáez‐Valero, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03514.x · Cited by 33
Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer’s disease
Singer, D. L., Lehmann, J., Hanisch, K., Härtig, W., & Hoffmann, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.201 · Cited by 33
Frontiers in Alzheimer’s disease therapeutics
Stone, J. G., Casadesús, G., Rothenberg, K. G., Siedlak, S. L., Wang, X., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310382817 · Cited by 32
Hu, Y., Meuret, C. J., Go, S., Yassine, H. N., & Nedelkov, D. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200203 · Cited by 33
He, X., Gao, J., Peng, L., Hu, T., Wan, Y., Zhou, M., Zhen, P., & Cao, H. (2020) · Gut · doi:10.1136/gutjnl-2020-322468 · Cited by 33
Galesic, A., Rakshit, A., Cutolo, G., Pacheco, R. P., Balana, A. T., Moon, S. P., & Pratt, M. R. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00716 · Cited by 32
Zuliani, I., Lanzillotta, C., Tramutola, A., Barone, E., Marzia Perluigi, A., Rinaldo, S., Paone, A., Cutruzzolà, F., Bellanti, F., Spinelli, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073746 · Cited by 32
Ngoh, G. A., & Jones, S. P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143263 · Cited by 33
Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau
Rani, L., Mittal, J., & Mallajosyula, S. S. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b11720 · Cited by 32
Regulation of Nuclear Factor-kappaB Function by O-GlcNAcylation in Inflammation and Cancer
Liu, A. R., & Ramakrishnan, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751761 · Cited by 41
Sumida, T., Stubbs, K. A., Ito, M., & Yokoyama, S. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06636j · Cited by 33
O-GlcNAcylation of Neuronal Proteins: Roles in Neuronal Functions and in Neurodegeneration
Lagerlöf, O., & Hart, G. W. (2014) · Advances in neurobiology · doi:10.1007/978-1-4939-1154-7_16 · Cited by 30
Self-citationNF-κB precursor, p105, and NF-κB inhibitor, IκBγ, are both elevated in Alzheimer disease brain
Huang, Y., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.074 · Cited by 31
Self-citationYang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 32
Kielbasa, W., Goldsmith, P., Donnelly, K. B., Nuthall, H. N., Shcherbinin, S., Fleisher, A., Hendle, J., DuBois, S. L., Lowe, S. L., Zhang, F. F., et al. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70020 · Cited by 30
Mechanisms of Enzymatic Glycosyl Transfer
Zhang, R., Yip, V. L. Y., & Withers, S. G. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00167-2 · Cited by 30
The Role of Stress‐Induced O‐GlcNAc Protein Modification in the Regulation of Membrane Transport
Fisi, V., Miseta, A., & Nagy, T. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1308692 · Cited by 30
SIRT1 regulates O-GlcNAcylation of tau through OGT
Lu, S., Yin, X., Wang, J., Gu, Q., Huang, Q., Jin, N., Chu, D., Xu, Z., Liu, F., & Qian, W. (2020) · Aging · doi:10.18632/aging.103062 · Cited by 31
Self-citationNew Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations
Mueller, T., Ouyang, X., Johnson, M. S., Qian, W., Chatham, J. C., Darley-Usmar, V. M., & Zhang, J. (2021) · Frontiers in Aging · doi:10.3389/fragi.2020.620382 · Cited by 30
Wei, X. L., & Li, L. (2009) · PubMed Central · Cited by 30
O-GlcNAc cycling modulates neurodegeneration
Gong, C., Liu, F., & Iqbal, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215395109 · Cited by 30
Self-citationO-GlcNAcylation in cellular functions and human diseases
Yang, Y. R., & Suh, P. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.007 · Cited by 32
Functional significance of O-GlcNAc modification in regulating neuronal properties
Hwang, H., & Rhim, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.006 · Cited by 32
Rojas-Pirela, M., Andrade-Alviárez, D., Rojas, V., Marcos, M., Salete-Granado, D., Chacón-Arnaude, M., Pérez-Nieto, M. Á., Kemmerling, U., Concepción, J. L., Michels, P. A. M., et al. (2025) · Open Biology · doi:10.1098/rsob.240239 · Cited by 31
Shen, X., Li, H., Zhang, B., Li, Y., & Zhu, Z. (2025) · Cells · doi:10.3390/cells14191506 · Cited by 33
Wei, X. L., Herbst, A. J., Ma, D., Aiken, J. M., & Li, L. (2011) · Journal of Proteome Research · doi:10.1021/pr2000495 · Cited by 29
Duquette, A., Pernègre, C., Carpentier, A. V., & Leclerc, N. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607680 · Cited by 38
Best, D., Chairatana, P., Glawar, A. F. G., Crabtree, E. V., Butters, T. D., Wilson, F. X., Yu, C., Wang, W.-B., Jia, Y., Adachi, I., et al. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.02.063 · Cited by 29
Kresge, H. A., Liu, D., Gupta, D. K., Moore, E. E., Osborn, K. E., Acosta, L. M. Y., Bell, S. P., Pechman, K. R., Gifford, K. A., Mendes, L. A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190813 · Cited by 28
Glycomics in Human Diseases and Its Emerging Role in Biomarker Discovery
Onigbinde, S. B., Adeniyi, M., Daramola, O. E., Chukwubueze, F. M., Bhuiyan, M. M. A. A., Nwaiwu, J. I., Bhattacharjee, T., & Mechref, Y. S. (2025) · Biomedicines · doi:10.3390/biomedicines13082034 · Cited by 36
The effect of O -GlcNAcylation on hnRNP A1 translocation and interaction with transportin1
Roth, S., & Khalaila, I. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.023 · Cited by 28
ZrO2 doped magnetic mesoporous polyimide for the efficient enrichment of phosphopeptides
Wang, X., Guo, Z.-Y., Zhang, Y., Chen, M., & Wang, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.069 · Cited by 28
Lee, Y., Park, J. W., Kim, S., Nam, K., Lee, W., Cho, H., & Han, I. (2019) · The FASEB Journal · doi:10.1096/fj.201901399rr · Cited by 28
Tools for functional dissection of site-specific O-GlcNAcylation
Gorelik, A., & van Aalten, D. M. F. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00052c · Cited by 30
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
Zuliani, I., Lanzillotta, C., Tramutola, A., Francioso, A., Pagnotta, S. E., Barone, E., Marzia Perluigi, A., & Domenico, F. D. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00978-4 · Cited by 29
Xu, M., Zhou, M., Li, S., Zhen, X., & Yang, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24805 · Cited by 27
Splicing factor SC35 promotes tau expression through stabilization of its mRNA
Qian, W., Iqbal, K., Grundke, I., Gong, C., & Liu, F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.017 · Cited by 28
Self-citationCheng, S., Xiao, B., & Luo, Z. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00506-4 · Cited by 31
Bukke, V. N., Villani, R., Moola, A., Wawrzyniak, A., Balawender, K., Orkisz, S., Ferraro, L., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207739 · Cited by 27
Cellular Biology of Tau Diversity and Pathogenic Conformers
Kang, S., Eskandari‐Sedighi, G., Hromádková, L., Safar, J., & Westaway, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590199 · Cited by 29
Metadata
- Authors
- Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X.
- Affiliations
- Johns Hopkins University (US)
- Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314; and Department of Biological Chemistry, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205
- Corresponding author
- Gong, Cheng-Xin
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10804-10809
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC490015
- OpenAlex
- W2164029759
- Cited by
- 775
- References
- 42
- Citations by year
- 2026: 29 · 2025: 50 · 2024: 38 · 2023: 36 · 2022: 44 · 2021: 63 · 2020: 57 · 2019: 38 · 2018: 46 · 2017: 45 · 2016: 33 · 2015: 23 · 2014: 36 · 2013: 24 · 2012: 35
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nanjing Medical University
- National Institutes of Health (HD13563)
- National Institute on Aging (AG19158, R01AG019158, AG16760, R01AG016760)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD013563, HD13563)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- O-GlcNAcylation, tau protein, tau hyperphosphorylation, Alzheimer's disease, tauopathy, neurofibrillary tangles, O-glycosylation, glucose metabolism, brain glucose uptake
- MeSH terms
- Acetylglucosamine, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Brain, Female, Glycosylation, Humans, Male, Mice, Inbred C57BL, Middle Aged, Phosphorylation, Starvation, PC12 Cells, tau Proteins, Rats, Wistar, Mice, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
